自身免疫性炎性肌病中的疼痛:范围综述
本范围综述检索PubMed和MEDLINE,纳入33项评估成人自身免疫性炎性肌病(AIM)疼痛的患者报告结局研究。疼痛和/或肌痛频率范围为64%至100%,AIM患者疼痛显著多于一般人群,与其他慢性风湿病疼痛程度相当。由于证据异质性和低质量,疼痛的显著临床相关因素尚无法确定,知识缺口持续存在。
要点
- AIM患者疼痛和/或肌痛频率范围为64%至100%。
- AIM患者疼痛显著多于一般人群,与其他慢性风湿病疼痛程度相当。
- 证据异质性和低质量限制了疼痛临床相关因素的确定。
核心结论
- 本综述提示AIM中疼痛负担相当大,但由于证据异质性和低质量,显著的知识缺口持续存在。
- 需要研究来描述AIM患者疼痛的轨迹。
研究设计与样本
- 范围综述,检索PubMed和MEDLINE,纳入超过5例成人AIM患者并使用患者报告结局测量评估疼痛的研究。
- 检索策略识别2831项研究,33项符合纳入标准。
主要发现
- 多数研究使用视觉模拟量表(n=14)和/或医学结局研究36项简表躯体疼痛量表(n=17)。
- 疼痛和/或肌痛频率范围为64%至100%。
- AIM患者疼痛显著多于一般人群,与其他慢性风湿病疼痛程度相当。
- 可识别AIM疼痛显著临床相关因素的结果不足。
局限性
- 证据存在异质性且质量低。
- 可识别疼痛显著临床相关因素的结果不足。
- 显著知识缺口持续存在。
- 需要研究来描述AIM患者疼痛的轨迹。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pain is considered a priority for research by adult patients with autoimmune inflammatory myopathy (AIM) and their families. Our aim was to review the literature for studies reporting on pain in adult AIM and to summarise their findings. METHODS: A scoping review was conducted searching for studies in PubMed and MEDLINE including more than five adult patients with AIM and assessing pain using a patient-reported outcome measure. Study population characteristics, pain measurement and clinical correlates of pain were extracted using a standardised protocol. RESULTS: The search strategy identified 2831 studies with 33 meeting inclusion criteria. Most studies used visual analogue scales (n=14) and/or the Medical Outcomes Study 36-Item Short Form Bodily Pain Scale (n=17). Frequency of pain and/or myalgias ranged from 64% to 100%. Subjects with AIM had significantly more pain than the general population and comparable pain to other chronic rheumatic diseases. Insufficient results were available to identify significant clinical correlates of pain in AIM. CONCLUSION: This review suggests that the burden of pain in AIM is considerable. Still, due to the heterogeneity and low quality of the evidence, significant knowledge gaps persist. Studies are needed to characterise pain trajectories of patients with AIM.
引用
- Leclair V, Tsui H, Hudson M, et al. Pain in autoimmune inflammatory myopathies: a scoping review. RMD Open. 2023. PMID: 36635001. doi:10.1136/rmdopen-2022-002591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。